HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mehmet Çakir Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

9/2015A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mehmet Çakir Research Topics

Disease

1Choroidal Neovascularization
09/2015
1Hepatitis B
01/2014

Drug/Important Bio-Agent (IBA)

1Ranibizumab (Lucentis)FDA Link
09/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2014